Fetcroja (cefiderocol)
- Region
- 🇪🇺 EU
- Active substance
- cefiderocol
- Company
- Shionogi B.V.
- Status
- Authorised
- Therapeutic area
- Gram-Negative Bacterial Infections
- EU approval
- Thu 23 Apr 2020
- Application
- EMEA/H/C/004829
- ATC
- J01D
- Official record
- www.ema.europa.eu
Indication
Fetcroja is indicated for the treatment of infections due to aerobic Gram-negative organisms in adults with limited treatment options (see sections 4.2, 4.4 and 5.1). Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Regulatory milestones
No milestones recorded in the last year.
Follow Fetcroja
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.